Evgeniya Ranneva
Skin Tech Pharma Group, Spain
Title: New medical approach for rejuvenation of the periorbital area
Biography
Biography: Evgeniya Ranneva
Abstract
Medical device CE class III is a new potential synergistic treatment for circles under the eyes and lymphedema. It is injection into the tear trough area, palpebral malar groove and upper eyelid. The main medical proposal for this new therapeutic approach is to minimize side effects during long-term therapy and be effective and save. The most common treatment option in the periorbital area is with cross linked Hyaluronic Acid (HA) and therefore, it is important to be aware of the usual complications such as swelling by overcorrection, nodules and edema by compression of lymphatic system. Every ampoule of 1.5 mL contains 5.0 mg/mL of non cross linked HA associated with active biorevitalization solution (BS 27.3 mg/mL) and helps improving the transport function of the actives from biorevitalization solution. The complex actives of BS are: Antioxidants, flavonoids, saponins, polyphenols, peptides and trace element. The results of the study indicate that injections of this product applied on the tear trough, the palpebral malar groove and also the upper eyelid area is a safe and effective treatment with minimum side effects. Medical device CE class III does not cause edema has no overcorrection issues and neither Tyndall effect. The best efficacy was observed in case of volume loss on the area of tear trough and palpebromalar groove combined with lymphedema. Although the results of treatment are very satisfactory, they require further investigation.